Results
|
|
6421.
|
|
|
|
6422.
|
|
|
|
6423.
|
|
|
|
6424.
|
|
|
|
6425.
|
|
|
|
6426.
|
|
|
|
6427.
|
|
|
|
6428.
|
|
|
|
6429.
|
|
|
|
6430.
|
Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer. [electronic resource] by
- Ota, Keiichi
- Azuma, Koichi
- Kawahara, Akihiko
- Hattori, Satoshi
- Iwama, Eiji
- Tanizaki, Junko
- Harada, Taishi
- Matsumoto, Koichiro
- Takayama, Koichi
- Takamori, Shinzo
- Kage, Masayoshi
- Hoshino, Tomoaki
- Nakanishi, Yoichi
- Okamoto, Isamu
Producer: 20160607
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
|
6431.
|
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors. [electronic resource] by
- Loi, Sherene
- Dushyanthen, Sathana
- Beavis, Paul A
- Salgado, Roberto
- Denkert, Carsten
- Savas, Peter
- Combs, Susan
- Rimm, David L
- Giltnane, Jennifer M
- Estrada, Monica V
- Sánchez, Violeta
- Sanders, Melinda E
- Cook, Rebecca S
- Pilkinton, Mark A
- Mallal, Simon A
- Wang, Kai
- Miller, Vincent A
- Stephens, Phil J
- Yelensky, Roman
- Doimi, Franco D
- Gómez, Henry
- Ryzhov, Sergey V
- Darcy, Phillip K
- Arteaga, Carlos L
- Balko, Justin M
Producer: 20161213
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|
|
|
6432.
|
|
|
|
6433.
|
|
|
|
6434.
|
|
|
|
6435.
|
PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients. [electronic resource] by
- Kakavand, Hojabr
- Wilmott, James S
- Menzies, Alexander M
- Vilain, Ricardo
- Haydu, Lauren E
- Yearley, Jennifer H
- Thompson, John F
- Kefford, Richard F
- Hersey, Peter
- Long, Georgina V
- Scolyer, Richard A
Producer: 20160510
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
|
6436.
|
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. [electronic resource] by
- Saha, Asim
- Aoyama, Kazutoshi
- Taylor, Patricia A
- Koehn, Brent H
- Veenstra, Rachelle G
- Panoskaltsis-Mortari, Angela
- Munn, David H
- Murphy, William J
- Azuma, Miyuki
- Yagita, Hideo
- Fife, Brian T
- Sayegh, Mohammed H
- Najafian, Nader
- Socie, Gerard
- Ahmed, Rafi
- Freeman, Gordon J
- Sharpe, Arlene H
- Blazar, Bruce R
Producer: 20131223
In:
Blood vol. 122
Availability: No items available.
|
|
|
6437.
|
|
|
|
6438.
|
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. [electronic resource] by
- Rosenberg, Jonathan E
- Hoffman-Censits, Jean
- Powles, Tom
- van der Heijden, Michiel S
- Balar, Arjun V
- Necchi, Andrea
- Dawson, Nancy
- O'Donnell, Peter H
- Balmanoukian, Ani
- Loriot, Yohann
- Srinivas, Sandy
- Retz, Margitta M
- Grivas, Petros
- Joseph, Richard W
- Galsky, Matthew D
- Fleming, Mark T
- Petrylak, Daniel P
- Perez-Gracia, Jose Luis
- Burris, Howard A
- Castellano, Daniel
- Canil, Christina
- Bellmunt, Joaquim
- Bajorin, Dean
- Nickles, Dorothee
- Bourgon, Richard
- Frampton, Garrett M
- Cui, Na
- Mariathasan, Sanjeev
- Abidoye, Oyewale
- Fine, Gregg D
- Dreicer, Robert
Producer: 20160607
In:
Lancet (London, England) vol. 387
Availability: No items available.
|
|
|
6439.
|
|
|
|
6440.
|
|